Carestream Health, consisting of Kodak’s former Health Group business (see IBO 1/15/07), officially began operating as an independent company in May. 454 Life Sciences and the Malaysian Genomics Resource Centre are collaborating on the characterization of tropical organisms and diseases. Axela Biosensors entered into a licensing and supply agreement for BioCheck’s reagents for use as research and clinical assays on its dotLab platform. In May, 454 Life Sciences and the Baylor College of Medicine announced the sequencing of an individual genome for less than $1 million using the GS FLX System. Dr. Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation, resigned from the board of Beckman Coulter in June. Helicos BioSciences named Dr. Patrice Milos vice president and chief scientific officer. She was previously executive director of Pfizer Global Research and Development. Helicos BioSciences named Chip Leveille, formerly of Affymetrix, vice president of Sales and Marketing. In June, Singulex, a developer of a single-molecule detection platform, raised $19.1 million in a private financing led by OrbiMed Advisors. MicroVacuum, a maker of biosensors, named Nanjing Sunshine Biotechnology as its Chinese distributor. NextGen’s 2006 revenues grew 41% to £1.4 million ($2.6 million) (see IBO 6/15/07). Going forward, it will focus on its fee-for-service business, which was 19% of sales. NextGen named Simon Barton CFO. He was previously with Screen Technology Group. In June, Applied Biosystems opened a 10,000 sq. ft. Application Support Center at its R&D headquarters in Foster City, California. The company has 20 centers worldwide. Applied Biosystems, the Discovery Channel and Egypt’s Supreme Council of Antiquities established the first laboratory in Egypt dedicated to testing ancient DNA samples. SEQUENOM elected Kathleen M. Wiltsey, who served as vice president of Amgen, to its Board. Syngene appointed Bartlett-Williams Scientific Researches and Imgen Technologies US distributors and named Bob Coyne, formerly with Fuji Film Life Sciences Imaging, US sales manager. Health Discovery announced the settlement of its patent infringement suit against Ciphergen Biosystems (see IBO 7/15/06), under which Ciphergen will pay the company $600,000 and receive a license to its support vector machines.